Annual sales increase 5% to $7,153 million, with adjusted EBITDA of $1,488 million and earnings per share of $0.36
Company advances strategic principles, with acquisition of Bartek Ingredients and review of non-core assets
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)-- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, consolidated sales of $1,701 million were up 6% versus $1,601 million in the fourth quarter of 2024. Operating income was ($16) million versus $147 million, while adjusted operating income of $223 million was up 17% versus $190 million in 2024. Adjusted EBITDA of $380 million was up 10% versus $347 million in the fourth quarter of 2024. Diluted earnings per share were ($0.06) in the fourth quarter, versus $0.06 in the prior year, while adjusted diluted EPS of $0.09 was up 13% versus $0.08.
In the fourth quarter, ICL incurred adjustments totaling $239 million, and the company views these charges as unusual. The adjustments include approximately $122 million for activities related to the execution of ICL’s new strategy. These efforts are essential in moving ICL forward and designed to help fund the company’s profitable growth engines – specialty crop nutrition and specialty food solutions. These advancements will help the company redirect its resources toward better-aligned opportunities and include the discontinuation of ICL’s LFP battery materials projects in St. Louis and in Spain, efficiency improvements at some of our R&D facilities in Israel, and an impairment of assets in the UK. These adjustments also include an $80 million provision for prior years following a Supreme Court ruling regarding water extraction fees in the Dead Sea concession area.
For the full year, consolidated sales were $7,153 million and up 5% versus $6,841 million in 2024. Operating income was $580 million versus $775 million in 2024, while adjusted operating income was $873 million in both 2025 and 2024. Annual adjusted EBITDA of $1,488 million was up slightly versus $1,469 million in 2024. Diluted earnings per share for 2025 were $0.18 versus $0.32 in 2024, while adjusted diluted EPS was $0.36 versus $0.38. Operating cash flow was $1,056 million in 2025. In 2025, the Company distributed approximately $224 million in dividends to its shareholders.
“ICL delivered a solid finish to 2025, with fourth quarter sales increasing 6% to $1.7 billion and adjusted EBITDA improving 10% to $380 million. All four of our segments delivered sales growth, with sales for our Industrial Products, Phosphate Solutions and Growing Solutions segments up 4% in the fourth quarter, and we remain committed to growing our leadership position in these segments,” said Elad Aharonson, president and CEO of ICL. “Throughout 2025, we benefitted from our distinctive global presence and relied on our regionally diversified operations to expand our specialties solutions offerings to our global customers using local production. This focus helped us to deliver a 5% increase in sales in 2025.
“This momentum is expected to carry us into 2026, and we are looking forward to executing against our new strategic principles in the coming years. For this year, we expect our two growth engines – specialty crop nutrition, which is part of Growing Solutions, and specialty food solutions, part of our Phosphate Solutions – to help drive improvement, and this will be via M&A, like our recent acquisition of Bartek Ingredients, and as we expand geographically. At the same time, we will stay focused on our core mission of driving profitable growth in all of our specialty businesses, while strengthening our leadership across all business segments.
“This focus has resulted in a review of our capital allocation priorities and an evaluation of non-synergistic and low-potential activities, including the discontinuation of our downstream expansion into cathode active materials for LFP batteries and a sales review of our Boulby operations in the UK, where we are exploring divestment opportunities. We expect to share updates on our strategic efforts throughout 2026 and look forward to strengthening and growing ICL for the long-term.”
For 2026, the Company expects consolidated adjusted EBITDA to be between $1.4 billion to $1.6 billion. For Potash sales volumes, the company expects between 4.5 million and 4.7 million metric tons in 2026. (1a)
The international earnings call will begin today at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (289) 819-1520 for international analysts, and the conference ID is 71097. Employees, the media and the public are invited to listen to the call using the webcast link found at ICL Group Investors Relations - Reports News & Events.
Financial Figures and non-GAAP Financial Measures
10-12/2025
10-12/2024
1-12/2025
1-12/2024
$
millions
% of
Sales
1,701
-
1,601
7,153
6,841
Gross profit
468
28
535
33
2,186
31
2,256
Operating income (loss)
(16)
(1)
147
9
580
8
775
11
Adjusted operating income(1)
223
13
190
12
873
Net income (loss) attributable to the Company's shareholders
(73)
(4)
70
4
226
3
407
6
Adjusted net income attributable to the Company’s shareholders(1)
121
7
104
465
484
Diluted earnings per share (in dollars)
(0.06)
0.06
0.18
0.32
Diluted adjusted earnings per share (in dollars)(2)
0.09
0.08
0.36
0.38
Adjusted EBITDA(2)
380
22
347
1,488
21
1,469
Cash flows from operating activities(3)
314
452
1,056
1,468
Purchases of property, plant and equipment and intangible assets(3)
252
267
824
713
See “Adjustments to Reported Operating and Net income (non-GAAP)” below.
(2)
See "Adjusted EBITDA and Diluted Adjusted Earnings Per Share for the periods of activity" below.
(3)
See “Condensed consolidated statements of cash flows (unaudited)” in the appendix below.
Segment Information
Industrial Products
The Industrial Products segment produces bromine from a highly concentrated solution in the Dead Sea and bromine‑based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces several grades of salts, magnesium chloride, magnesia-based products, phosphorus-based products and functional fluids.
Results of operations and key indicators
$ millions
Segment Sales
296
280
1,254
1,239
Sales to external customers
294
275
1,238
1,220
Sales to internal customers
2
5
16
19
Segment Operating Income
52
55
220
224
Depreciation and amortization
15
60
57
Segment EBITDA
68
281
Capital expenditures
38
81
94
Significant highlights for the fourth quarter
Results analysis for the period October – December 2025
Expenses
Operating income
Q4 2024 figures
(225)
Quantity
(13)
10
Price
24
Exchange rates
(8)
Raw materials
1
Energy
Transportation
Operating and other expenses
(20)
Q4 2025 figures
(244)
Potash
The Potash segment produces and sells mainly potash, salts, magnesium and electricity. Potash is produced in Israel using an evaporation process to extract potash from the Dead Sea at Sodom and in Spain using conventional mining from an underground mine. The segment also produces and sells pure magnesium, magnesium alloys and chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom, which supplies electricity and steam to ICL facilities in Israel with any surplus electricity sold to external customers.
473
422
1,714
1,656
Potash sales to external customers
370
315
1,308
1,237
Potash sales to internal customers
27
30
89
95
Other and eliminations(1)
76
77
317
324
Gross Profit
163
61
622
650
86
69
298
250
64
254
242
150
130
552
492
124
116
367
332
Potash price - CIF ($ per tonne)
348
285
316
299
Primarily includes salt produced in Spain, metal magnesium-based products, chlorine and sales of surplus electricity produced by ICL’s power plant at the Dead Sea in Israel.
Additional segment information
Global potash market - average prices and imports:
Average prices
VS Q4 2024
7-9/2025
VS Q3 2025
Granular potash – Brazil
CFR spot
($ per tonne)
355
288
23.3%
360
(1.4)%
Granular potash – Northwest Europe
CIF spot/contract
(€ per tonne)
365
338
8.0%
0.0%
Standard potash – Southeast Asia
373
292
27.7%
0.8%
Potash imports
To Brazil
million tonnes
2.5
2.9
(13.8)%
4.0
(37.5)%
To China
3.4
17.6%
2.4
66.7%
To India
1.0
1.2
(16.7)%
0.9
11.1%
Sources: CRU (Fertilizer Week Historical Price: December 2025), SIACESP (Brazil), United Port Services (Brazil), FAI (India), Chinese customs data, Global Trade Tracker (GTT).
Potash – Production and Sales
Thousands of tonnes
Production
1,222
1,178
4,377
4,502
Total sales (including internal sales)
1,200
1,259
4,320
4,556
Closing inventory
286
229
Fourth quarter 2025
Full year 2025
(353)
(11)
(10)
(6)
(17)
(387)
Phosphate Solutions
The Phosphate Solutions segment operates ICL’s phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.
10-12/2025(1)
1-12/2025(2)
518
507
2,333
2,215
471
475
2,156
2,049
47
32
177
166
342
358
45
51
186
191
132
528
549
336
340
For Q4 2025, Phosphate Specialties accounted for $ 324 million of segment sales, $ 41 million of operating income, $ 12 million of D&A and $ 53 million of EBITDA, while Phosphate Commodities accounted for $ 194 million of segment sales, $ 35 million of operating income, $ 33 million of D&A and represented $ 68 million of EBITDA.
For 2025, Phosphate Specialties accounted for $1,332 million of segment sales, $157 million of operating income, $49 million of D&A and $206 million of EBITDA, while Phosphate Commodities accounted for $1,001 million of segment sales, $185 million of operating income, $137 million of D&A and $322 million of EBITDA.
Global Phosphate Commodities market - average prices per tonne:
DAP
CFR India Bulk Spot
721
637
13%
807
(11)%
TSP
CFR Brazil Bulk Spot
558
500
12%
603
(7)%
SSP
CPT Brazil inland 18-20% P2O5 Bulk Spot
287
270
6%
303
(5)%
Sulphur
Bulk FOB Adnoc monthly Bulk contract
394
139
183%
271
45%
Source: CRU (Fertilizer Week Historical Prices, December 2025).
(426)
(21)
(5)
23
(36)
17
(442)
Growing Solutions
The Growing Solutions segment aims to achieve global leadership in plant nutrition by enhancing its position in its core markets of agriculture, ornamental horticulture, turf and landscaping, and by targeting high-growth markets such as Brazil, India, and China. The segment leverages its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration into potash, phosphate and polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. The segment continuously works to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consists of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers, straights (MKP/MAP/PeKacid), FertilizerpluS, soil and foliar micronutrients, biostimulants, soil conditioners, seed treatment products and adjuvants.
467
439
2,063
1,950
435
2,048
1,932
18
41
135
128
20
78
74
213
202
44
98
Regional highlights:
Product highlights:
(408)
(9)
(25)
(14)
Financing expenses, net
Net financing expenses in the fourth quarter of 2025 totaled $45 million, compared to $33 million in the corresponding quarter last year, reflecting an increase of $12 million.
Tax expenses
In the fourth quarter of 2025, the Company’s reported tax expenses amounted to $2 million, compared to $33 million in the corresponding quarter of last year, reflecting an effective tax rate of 3% and 29%, respectively. Adjusted tax expenses totaled $47 million, compared to $42 million in the corresponding period of last year, reflecting an effective tax rate of 26% and 27%, respectively.
Liquidity and Capital Resources
As of December 31, 2025, the Company’s cash, cash equivalents, short-term investments and deposits amounted to $496 million compared to $442 million as of December 31, 2024. In addition, the Company maintained about $1.1 billion of unused credit facilities, as of December 31, 2025.
Outstanding net debt
As of December 31, 2025, ICL’s net financial liabilities amounted to $2,260 million, an increase of $409 million compared to December 31, 2024. In addition, as of December 31, 2025, the fair value balance of currency and interest rate swap transactions (CCS) economically reduces our finance liabilities by approximately $51 million.
Debentures
In December 2025, the Company repaid NIS 33 million (approximately $10 million) of Series G debentures, as scheduled.
Subsequent to date of the report, in January 2026, the Company repaid a $46 million private placement bond, as scheduled.
Credit facilities
Sustainability-linked Revolving Credit Facility (RCF)
As of December 31, 2025, the Company had utilized about $497 million of its $1,550 million credit facility framework.
Securitization
In December 2025, the Company signed a new securitization agreement with four international banks for a committed amount of $350 million and an additional uncommitted $100 million, maturing in December 2030. This agreement replaces the prior securitization facility, which recently matured, and includes slightly improved terms compared to the previous agreement. As of December 31, 2025, ICL had utilized approximately $325 million of the facility.
Ratings and financial covenants
Fitch Ratings
In May 2025, Fitch Ratings reaffirmed the Company’s long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.
S&P Ratings
In July 2025, the S&P credit rating agency reaffirmed the Company’s international credit rating and senior unsecured rating of 'BBB-' with a stable rating outlook. In addition, the S&P Maalot credit rating agency reaffirmed the Company’s credit rating of 'ilAA' with a stable rating outlook.
Financial covenants
As of December 31, 2025, the Company was in compliance with all of the financial covenants stipulated in its financing agreements.
Dividend Distribution
In connection with ICL’s fourth quarter 2025 results, the Board of Directors declared a dividend of 4.65 cents per share, or approximately $60 million. The dividend will be paid on March 25, 2026. The record date is March 10, 2026.
About ICL
ICL Group Ltd. is a global leader in agriculture, food and industrial solutions, utilizing its unique mineral resources and extensive expertise to address key sustainability challenges related to food security and access to essential minerals. ICL is focused on driving long-term growth through its specialty agriculture and food businesses, while strategically managing its bromine, potash, and phosphate mineral resources. ICL’s global professional workforce is dedicated to expanding its growth engines and efficiently operating – both structurally and economically – while maintaining and optimizing its core operations. The Company’s operations are organized under four segments: Industrial Products (Bromine), Potash, Phosphate Solutions and Growing Solutions.
We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below. Some of these items may recur. We calculate our adjusted net income attributable to the Company’s shareholders by adjusting our net income attributable to the Company’s shareholders to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under “Consolidated adjusted EBITDA, and diluted adjusted Earnings Per Share for the periods of activity” below, which were adjusted for in calculating the adjusted operating income.
You should not view adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company’s shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
(1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The Company provides guidance for consolidated adjusted EBITDA and for its Potash business the company provides sales volumes guidance. The Company believes this information provides greater transparency, as the price of potash has stabilized over the past few years and consolidated adjusted EBITDA is now a more relevant metric for investors to evaluate the company’s performance and compare its financial results between periods.
We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company’s results of operations. This discussion is based in part on management’s best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.
Adjustments to Reported Operating and Net income (non-GAAP)
Charges related to the security situation in Israel(1)
54
Impairment and write-off of assets and provision for site closure(2)
122
131
35
Provision for early retirement(3)
Legal proceedings(4)
80
Total adjustments to operating income
239
43
293
Adjusted operating income
Net income (loss) attributable to the shareholders of the Company
Total tax adjustments(5)
(45)
(54)
Total adjusted net income - shareholders of the Company
For 2025 and 2024, reflects charges relating to the security situation in Israel.
For 2025, reflects mainly asset write-offs resulting from the closure of LFP projects, impairment of assets in the Company’s UK operation, and a small R&D activity in Israel, following the implementation of the Company’s strategy, including efficiency and cost-reduction programs. It also includes asset write-offs related to a fire at Ashdod Port and two portfolio companies due to failed business continuity and funding. For 2024, reflects mainly a write-off of assets resulting from the closure of small sites in Israel and Turkey.
For 2025 and 2024, reflects provisions for early retirement due to restructuring at certain sites, as part of the Company’s global efficiency plan.
For 2025, reflects a provision for prior years following a Supreme Court ruling regarding water extraction fees in the Dead Sea concession area. For 2024, reflects reimbursement of arbitration costs associated with the Ethiopian potash project.
For 2025 and 2024, reflects the tax impact of adjustments made to operating income.
Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity
Calculation of adjusted EBITDA was made as follows:
Net income (loss)
(63)
464
140
Taxes on income
161
172
Less: Share in earnings of equity-accounted investees
157
615
596
Adjustments(1)
Total adjusted EBITDA
See "Adjustments to Reported Operating and Net income (non-GAAP)" above.
Calculation of diluted adjusted earnings per share was made as follows:
Total tax adjustments
Adjusted net income - shareholders of the Company
Weighted-average number of diluted ordinary shares outstanding (in thousands)
1,290,669
1,290,330
1,291,395
1,290,039
The diluted adjusted earnings per share is calculated by dividing the adjusted net income‑shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands).
Consolidated Results Analysis
(1,454)
Total adjustments Q4 2024*
Adjusted Q4 2024 figures
(1,411)
(49)
36
(72)
(39)
Adjusted Q4 2025 figures
(1,478)
Total adjustments Q4 2025*
(239)
(1,717)
*
See "Adjustments to reported Operating and Net income (non-GAAP)" above.
Security situation in Israel
In October 2023, the Israeli government declared a state of war in response to attacks on its civilians in the southern region of the country, which subsequently escalated to other areas. On October 9, 2025, Israel signed a ceasefire agreement. The security situation over the past two years has created several challenges, including disruptions to supply chains and shipping routes, personnel shortages due to recurring rounds of mobilization for reserve duty, additional costs to protect Company sites/assets, effects of reluctance to perform contractual obligations in Israel during hostilities, various bans and limitations on trade and cooperation with Israel related entities, and fluctuations in foreign currency exchange rates relative to the Israeli shekel. Additionally, ongoing regional tensions – including Houthis threats to commercial vessels – continue to disrupt shipping routes and commercial shipping arrangements, leading to increased shipping costs.
We continue to take measures to ensure the safety of our employees and business partners, as well as the communities in which we operate. We have also implemented supportive measures to accommodate those of our employees who are called for reserve duty, aiming to minimize any potential impact on our business, and to avoid disruptions to production activities at our facilities in Israel.
We continuously monitor developments and will take all necessary actions to minimize any negative consequences to our operations and assets. As of the reporting date, the security situation has not had a material impact on our business results. However, its future effects remain uncertain due to the unpredictable nature and duration of the conflict.
Forward-looking Statements
This announcement contains statements that constitute “forward‑looking statements”, many of which can be identified by the use of forward‑looking words such as “anticipate”, “believe”, “could”, “expect”, “should”, “plan”, “intend”, “estimate”, “strive”, “forecast”, “targets” and “potential”, among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.
Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding the Company's intent, belief or current expectations. Forward‑looking statements are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:
Changes in exchange rates or prices compared to those we are currently experiencing; the effects of the ongoing security situation in Israel, including the nature and duration of related conflicts; loss or impairment of business licenses or mineral extractions permits or concessions, including our ability to win the new concession at the Dead Sea in 2030 ; volatility of supply and demand and the impact of competition; the difference between actual reserves and the Company reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at the Company's seaport shipping facilities or regulatory restrictions affecting the Company's ability to export products overseas; general market, political or economic conditions in the countries in which the Company operates, including tariffs and trade policies; price increases or shortages with respect to the Company's principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the Company plants; labor disputes, slowdowns and strikes involving the Company employees; pension and health insurance liabilities; disruptions from pandemics that may impact the Company sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in the Company evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of the Company, or the Company service providers', information technology systems or breaches of the company, or the Company service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the Company cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the Company's businesses; changes in demand for the Company's fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company control; sales of the company magnesium products being affected by various factors that are not within the Company control; the Company ability to secure approvals and permits from the authorities in Israel to continue the Company's phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the Company's workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of security tension in Israel and the resulting disruptions to the Company supply and production chains; filing of class actions and derivative actions against the Company, its executives and Board members; the Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under ”Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the US Securities and Exchange Commission (the “SEC”) on March 13, 2025 (the “Annual Report”).
Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risks and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.
This announcement for the fourth quarter of 2025 (the “Quarterly Report”) should be read in conjunction with the Annual Report and the report for the first, second and third quarters of 2025 published by the Company (the “prior quarterly reports”), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.
Appendix:
Condensed Consolidated Statements of Financial Position as of (Unaudited)
December 31,
2025
2024
Current assets
Cash and cash equivalents
291
327
Short-term investments and deposits
205
115
Trade receivables
1,365
1,260
Inventories
1,934
1,626
Prepaid expenses and other receivables
369
258
Total current assets
4,164
3,586
Non-current assets
Deferred tax assets
180
143
Property, plant and equipment
6,785
6,462
Intangible assets
955
869
Other non-current assets
329
261
Total non-current assets
8,249
7,735
Total assets
12,413
11,321
Current liabilities
Short-term debt
876
384
Trade payables
1,157
1,002
Provisions
58
63
Other payables
1,040
867
Total current liabilities
3,131
2,316
Non-current liabilities
Long-term debt and debentures
1,880
1,909
Deferred tax liabilities
502
481
Long-term employee liabilities
390
331
Long-term provisions and accruals
231
Other
Total non-current liabilities
3,039
3,018
Total liabilities
6,170
5,334
Equity
Total shareholders’ equity
5,983
5,724
Non-controlling interests
260
263
Total equity
6,243
5,987
Total liabilities and equity
Condensed Consolidated Statements of Income (Unaudited)
(In millions except per share data)
For the three-month
period ended
December 31
For the year ended
Cost of sales
1,233
1,066
4,967
4,585
Selling, transport and marketing expenses
1,114
General and administrative expenses
73
259
Research and development expenses
Other expenses
Other income
(23)
(38)
Finance expenses
93
71
181
Finance income
(48)
(159)
(41)
Finance expenses, net
Share in earnings of equity-accounted investees
Income (loss) before taxes on income
(61)
114
441
636
Net income attributable to non-controlling interests
Net income (loss) attributable to shareholders of the Company
Earnings per share attributable to shareholders of the Company:
Basic earnings per share (in dollars)
Weighted-average number of ordinary shares outstanding:
Basic (in thousands)
1,290,260
1,290,580
1,289,968
Diluted (in thousands)
Condensed Consolidated Statements of Cash Flows (Unaudited)
December 31, 2025
December 31, 2024
Cash flows from operating activities
Adjustments for:
Fixed assets impairment
111
14
Exchange rate, interest and derivative, net
59
152
Change in provisions
26
(50)
990
897
Change in inventories
(145)
(102)
(210)
(7)
Change in trade receivables
Change in trade payables
110
87
100
Change in other receivables
66
(22)
39
Change in other payables
Net change in operating assets and liabilities
82
158
Income taxes paid, net of refund
(37)
(151)
(98)
Net cash provided by operating activities
Cash flows from investing activities
Proceeds (payments) from deposits, net
(82)
(86)
56
Purchases of property, plant and equipment and intangible assets
(252)
(267)
(824)
(713)
Proceeds (payments) from divestiture of assets and businesses, net of transaction expenses
Proceeds (payments) from settlement of derivatives, net
Interest received
Business combinations
(12)
(74)
Net cash used in investing activities
(333)
(270)
(915)
(694)
Cash flows from financing activities
Dividends paid to the Company's shareholders
(62)
(68)
(224)
(251)
Receipts of long-term debt
278
1,666
889
Repayments of long-term debt
(183)
(383)
(1,599)
(1,302)
Receipts (repayments) of short-term debt, net
92
146
Interest paid
(43)
(117)
(122)
Payments from transactions in derivatives
Dividend paid to the non-controlling interests
(64)
(57)
Net cash used in financing activities
(227)
(195)
(846)
Net change in cash and cash equivalents
Cash and cash equivalents as of the beginning of the period
356
393
420
Net effect of currency translation on cash and cash equivalents
Cash and cash equivalents as of the end of the period
Operating segment data
Industrial
Products
Phosphate
Solutions
Growing
Activities
Reconciliations
Consolidated
For the three-month period ended December 31, 2025
Sales to external parties
427
Inter-segment sales
46
Total sales
195
310
333
Segment operating income (loss)
(24)
Other expenses not allocated to the segments
Income (loss) before income taxes
Depreciation, amortization and impairment
119
268
Operating segment data (cont'd)
For the three-month period ended December 31, 2024
49
(90)
344
313
(33)
Income before income taxes
164
Capital expenditures as part of business combination
Information based on geographical location
The following table presents the distribution of the operating segments sales by geographical location of the customer:
sales
China
337
274
Brazil
276
USA
Israel
India
Spain
United Kingdom
Germany
65
France
48
Austria
All other
306
362
Total
Investor and Press Contact – Global Peggy Reilly Tharp VP, Global Investor Relations +1-314-983-7665 Peggy.ReillyTharp@icl-group.com
Investor and Press Contact - Israel Adi Bajayo VP, ICL Spokesperson and Israel IR +972-3-6844459 Adi.Bajayo@icl-group.com
Multimedia Files: